Illinois General Assembly - Full Text of HB3972
Illinois General Assembly

  Bills & Resolutions  
  Compiled Statutes  
  Public Acts  
  Legislative Reports  
  IL Constitution  
  Legislative Guide  
  Legislative Glossary  

 Search By Number
 (example: HB0001)
Search Tips

Search By Keyword

Full Text of HB3972  103rd General Assembly

HB3972 103RD GENERAL ASSEMBLY

  
  

 


 
103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
HB3972

 

Introduced 2/17/2023, by Rep. Robert "Bob" Rita

 

SYNOPSIS AS INTRODUCED:
 
30 ILCS 500/25-210 new

    Amends the Illinois Procurement Code. Provides that the Department of Central Management Services, in consultation with the Chief Procurement Officer, shall implement and develop a program to establish a State prescription generic drug label for the purpose of increasing competition in the generic drug market and lowering generic drug prices for all purchasers. Provides the label shall include a list of the 100 most commonly prescribed drugs. Provides that the Department shall contract with one or more generic drug manufacturers to manufacture certain generic drugs on behalf of the State and participating entities. Provides for the adoption of rules.


LRB103 29592 DTM 55987 b

 

 

A BILL FOR

 

HB3972LRB103 29592 DTM 55987 b

1    AN ACT concerning finance.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Procurement Code is amended by
5adding Section 25-210 as follows:
 
6    (30 ILCS 500/25-210 new)
7    Sec. 25-210. Generic prescription drug contracting. The
8Department of Central Management Services, in consultation
9with the Chief Procurement Officer, shall implement and
10develop a program to establish a State prescription generic
11drug label for the purpose of increasing competition in the
12generic drug market and lowering generic drug prices for all
13purchasers. The label shall include a list of the 100 most
14commonly prescribed drugs. The Department shall contract with
15one or more generic drug manufacturers to manufacture certain
16generic drugs on behalf of the State and participating
17entities. The Department shall adopt rules necessary to
18implement and administer the program created under this
19Section.